Get started
Author

Leandro Ernesto Mainetti

Observed names: L E Mainetti, L. E. Mainetti, L.E. Mainetti, LE Mainetti, Leandro E Mainetti, Leandro E. Mainetti, Leandro Mainetti, Mainetti, Leandro E, Mainetti, Leandro Ernesto
Observed institutions: Consejo Nacional de Investigaciones Científicas y Técnicas, Wayne State University, National University of Rosario, The Barbara Ann Karmanos Cancer Institute, Centro Científico Tecnólogico - Rosario, Instituto de Oncología de Rosario
OpenAlex ID: A5113726495
Metronomic Chemotherapy: Changing the Paradigm That More Is Better
2009 · O. Graciela Scharovsky, L. E. Mainetti, et al. · Current Oncology · 174
PDF
Safety and Therapeutic Effect of Metronomic Chemotherapy with Cyclophosphamide and Celecoxib in Advanced Breast Cancer Patients
2013 · Herman A Perroud, Maria José Rico, et al. · Future Oncology · 52
Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
2015 · Herman Andres Perroud, Carlos Maria Alasino, et al. · Cancer Chemotherapy and Pharmacology · 45
The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With Cyclophosphamide
2009 · Viviana R. Rozados, Leandro E. Mainetti, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 33
Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas
2013 · L.E. Mainetti, M.J. Rico, et al. · Annals of Oncology · 31
PDF
Bone-induced c-kit expression in prostate cancer: A driver of intraosseous tumor growth
2014 · Leandro E. Mainetti, Xiaoning Zhe, et al. · International Journal of Cancer · 28
Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients
2016 · Won Jin Cho, Daniel S. M. Oliveira, et al. · Journal of Translational Medicine · 18
PDF
Antitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide combined with celecoxib on murine mammary adenocarcinomas
2010 · Leandro E. Mainetti, Viviana R. Rozados, et al. · Journal of Cancer Research and Clinical Oncology · 17
Achievements and challenges in the use of metronomics for the treatment of breast cancer
2020 · O. Graciela Scharovsky, María José Rico, et al. · Biochemical Pharmacology · 13
PDF
Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
2016 · Adriana Rosé, Nicolas André, et al. · ecancermedicalscience · 11
PDF
Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model.
2012 · M J Rico, V R Rozados, et al. · PubMed · 11
Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models
2020 · Leandro E. Mainetti, María José Rico, et al. · Oncotarget · 9
PDF
Comparative Effectiveness of Two Metronomic Chemotherapy Schedules—Our Experience in the Preclinical Field
2014 · M. J. Rico, H. A. Perroud, et al. · Cancer Investigation · 6
[Immunomodulation and antiangiogenesis in cancer therapy. From basic to clinical research].
2012 · O Graciela Scharovsky, Pablo Matar, et al. · PubMed · 5
Metronomic therapy with Cyclophosphamide or Doxorubicin inhibits mouse mammary adenocarcinoma growth and metastasis development
2005 · Leandro E. Mainetti, Viviana R. Rozados, et al. · Cancer Research · 5
Abstract 3: Metronomic chemotherapy with cyclophosphamide (Cy) and the repositioned drug losartan (Los) for the treatment of M-234p triple negative murine mammary adenocarcinoma
2018 · Julian Guercetti, Leandro E. Mainetti, et al. · Cancer Research · 4
Intestinal ABC transporters: Influence on the metronomic cyclophosphamide-induced toxic effect in an obese mouse mammary cancer model
2024 · María Manuela Barranco, Felipe Zecchinati, et al. · Toxicology and Applied Pharmacology · 3
Nonclassical Roles for IFN-γ and IL-10 in a Murine Model of Immunoedition
2020 · Antonela Del Giúdice, Lucas Pagura, et al. · Future Science OA · 2
Antitumor Activity of New Chemical Compounds in Triple Negative Mammary Adenocarcinoma Models
2020 · María V Giolito, Cristian M Camacho, et al. · Future Science OA · 2
Abstract 2745: Drug repositioning for triple negative breast and colorectal cancers treatment: Exploring the use of metformin and propranolol
2020 · M Virginia Baglioni, Luciano E. Anselmino, et al. · Cancer Research · 1
1562 Objective evaluation of quality of life in patients with advanced breast cancer treated with metronomic chemotherapy
2015 · H.A. Perroud,, C.M. Alasino, et al. · European Journal of Cancer · 1
Abstract P2-16-11: Metronomic Chemotherapy with Cyclophosphamide (CY) and Doxorubicin (DOX) Inhibits Tumor Growth and Metastases Development of Mouse Mammary Adenocarcinoma M-406
2010 · LE Mainetti, MV Fernandez Zenobi, et al. · Cancer Research · 1
Abstract 1125: Altered therapeutic response to metronomic chemotherapy in a metabolic syndrome model of mice bearing a mammary adenocarcinoma: Implication of intestinal ABC transporters
2021 · María Manuela Barranco, Martín Habib, et al. · Cancer Research
Supplementary Materials - Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
2020 · Giolito, Maria V, Camacho, Cristian M, et al. · Figshare
Pd32-11 Gene Expression Analysis of Bone Metastasis and Circulating Tumor Cells From Metastatic Castrate-resistant Prostate Cancer Patients
2016 · Won-Jin Cho, Michael Cher, et al. · The Journal of Urology
PDF
Works count: 33
Citation count: 472
H-index: 11
I10-index: 11
Year
Topic
Type